


Searching News Database: EGP-437
HSMN NewsFeed - 9 Jan 2009
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
